Quantcast
Last updated on April 16, 2014 at 10:52 EDT

Latest Ribbon symbolism Stories

2014-02-25 23:03:30

Rhode Island Medical Imaging (RIMI) once again donated $2,500 to support the Providence College Women’s Basketball Program’s fight to end breast cancer. East Providence, RI (PRWEB) February 25, 2014 Rhode Island Medical Imaging (RIMI) was pleased to once again donate $2,500 to support the Providence College (PC) Women’s Basketball Program’s fight to end breast cancer. The donation covered the purchase of the ‘Pink Out Friartown’ uniforms, which were worn during the February...

2014-02-25 23:00:27

Award recognizes Humility of Mary Health Partners’ exceptional patient care and treatment. Youngstown, Ohio (PRWEB) February 25, 2014 Joanie Abdu Comprehensive Breast Care Center, St. Elizabeth Health Center, is one of America’s Best Breast Centers, according to Women’s Choice, which identifies services women most recommend and trust. “Breast care is extremely vital to women’s health and we want them to know that Joanie Abdu Comprehensive Breast Care Center has met the highest...

2014-02-25 12:27:52

Hyperthermia has shown to greatly improve cancer treatment outcomes when combined with radiation and chemotherapy, but Beverly Hills Thermal Medicine is one of only a few centers to offer it. BEVERLY HILLS, Calif., Feb. 25, 2014 /PRNewswire/ -- /Beverly Hills Thermal Medicine/- Hyperthermia treatments have shown to double response rates of chemotherapy and radiation without side effects, and are an integral part of cancer treatment in Europe, but despite this, it has not gained...

2014-02-24 23:24:03

Grassroots Events Across USA on 3.3.14 Focus on Aggressive But Lesser-known Breast Cancer with Disproportionate Impact on Younger Women, African-American Women and Women with BRCA1 Gene Mutation Norwood, NJ (PRWEB) February 24, 2014 Breast cancer treatments and public awareness have advanced in recent years; however, Triple Negative Breast Cancer (TNBC) lags behind with no targeted treatments for patients and minimal recognition of its existence. With up to 20% of breast cancers...

2014-02-24 23:04:09

Christina Berger is named Development Director of ABCD: After Breast Cancer Diagnosis Glendale, WI (PRWEB) February 24, 2014 ABCD: After Breast Cancer Diagnosis has appointed Christina Berger its first Development Director. Formerly a Senior Manager PDP on Baker Tilly Virchow Krause’s Strategic Tax Team and a participant in its distinct leadership development program, Christina brings extraordinary relationship management and strategic planning skills to ABCD. An alumna of Marquette...

2014-02-24 16:23:52

NORWALK, Conn., Feb. 24, 2014 /PRNewswire/ -- UBM Medica US announces that Diagnostic Imaging, a leading online community for medical imaging professionals, explored in two related blogs the latest controversy around a recent screening mammography study. Radiologists Ken Keller, MD, and Eric Postal, MD, both regular contributors to Diagnostic Imaging, offered their remarks related to a recent BMJ study that found annual mammograms for women aged 40 to 59 do not reduce breast cancer mortality...

2014-02-24 12:27:41

WAYNE, Pa., Feb. 24, 2014 /PRNewswire/ -- This month, FemmePharma, the pharmaceutical development company specializing in women friendly products, introduces FemmePharma Consumer Healthcare with the launch of www.FemmePharmaForYou.com. "Almost ten years ago, we launched FemmePharma to develop innovative therapeutics for women in areas of high unmet medical need that profoundly impact a woman's quality of life," says founder Gerianne Tringali DiPiano. FemmePharmaForYou is a...

2014-02-21 23:21:11

What To Do About The New Controversies Regarding Mammograms Thousand Oaks, California (PRWEB) February 21, 2014 The controversy about screening mammogram rages on. Last week, the Canadian National Breast Screening Study published its conclusion that "annual mammography in women aged 40-59 does not reduce mortality from breast cancer beyond that of physical examination." Some people may interpret this result as women don't need mammogram anymore. On the other hand, we have...

2014-02-20 08:32:05

SEATTLE, WA and BOULDER, CO, Feb. 20, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) and Array BioPharma Inc. (NASDAQ: ARRY) today announced the initiation of a Phase 1b trial of ONT-380 (ARRY-380) in combination with Kadcyla® (ado-trastuzumab emtansine or TDM-1) in patients with metastatic HER2+ breast cancer. ONT-380 is an orally active, reversible and selective small-molecule HER2 inhibitor invented by Array and being developed by Oncothyreon in collaboration with Array....

2014-02-19 23:28:11

RF Safe supports breast cancer awareness by warning women to make their bra a "no phone zone" as a new study raises concerns over a possible association between cell phone radiation exposure and breast cancer in young women. San Francisco, CA (PRWEB) February 19, 2014 RF Safe claims a research team, led by Dr. Lisa Bailey, and one of California’s top breast surgeons, studied four young women – aged from 21 to 39 years old – with multifocal invasive breast cancer that...